ScreenerHero

TVGN Tevogen Inc.

NAS · US · Healthcare · Biotechnology · tevogen.com
6.490USD0.00%Mkt Cap: 42.26M $P/E: —

Tevogen Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, wh…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap42.26M USD
Enterprise Value59.42M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-26.28M USD
Revenue/Share—
Last Price6.490 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees18
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.79
EV/Revenue—
P/S—
P/B-1.56
EPS (TTM)-6.74
EPS (Forward)—
52W Range
3.6367% of range43.65
52W High43.65 USD
52W Low3.636 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE319.08%
ROA-599.49%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-12.33M USD
CapEx (TTM)64.44K USD
FCF Margin—
FCF Yield-7.22%
Net Debt8.36M USD
Net Debt/EBITDA-0.39
Balance Sheet
Debt/Equity-0.91
Current Ratio0.33
Quick Ratio0.20
Book Value/Sh-4.16 USD
Cash/Share0.17 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateMar 6, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.6.51M
Float841.62K
Insiders72.08%
Institutions1.65%
Short Interest
Short Ratio7.0d
Short % Float2.15%
Short % Out.0.90%
Shares Short58.33K
Short (prev mo.)58.74K
Technical
SMA 506.930 (-6.3%)
SMA 2009.284 (-30.1%)
Beta0.20
S&P 52W Chg16.45%
Avg Vol (30d)7.46K
Avg Vol (10d)4.16K
Technical Indicators
RSI (14)41.2
MACD-0.0807
MACD Signal0.0518
MACD Hist.-0.1325
BB Upper8.100 USD
BB Middle7.174 USD
BB Lower6.248 USD
BB Width25.83%
ATR (14)0.5049 USD
Vol Ratio (20d)0.20x